BOOSTER EFFECTS WITH AUTOIMMUNE TREATMENTS IN PATIENTS WITH POOR RESPONSE TO INITIAL COVID-19 VACCINE
Brief description of study
The main reason this research study is being done is to see if an additional COVID-19 vaccine (a booster) will help people with autoimmune disease who are taking certain medications that weaken their immune system develop a better response to the vaccine. The study doctors also want to see if temporarily stopping some medications (such as mycophenolate mofetil, mycophenolic acid, and methotrexate) around the time of vaccination will help the immune system respond to the COVID-19 vaccination.
Clinical Study Identifier: s21-01043
ClinicalTrials.gov Identifier: NCT05000216
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
